Stock Market News for February 12, 2026
853 news published.
Capital Markets, Debt Moves and Financing Alerts
W. P. Carey Inc. (WPC) priced €1.0 billion of senior unsecured notes, a sizeable European‑currency issuance that helps the REIT manage duration and cross‑border liquidity needs while setting a benchmark for property‑sector funding costs.
Existing corporate financings remain in focus—Advanced Drainage Systems (WMS) and Royal Caribbean Group (RCL) earlier priced large note deals that continue to shape credit spreads for industrials and travel operators.
Energy, Materials and Trade Policy
Novonix (NVX) and broader battery supply chains are under scrutiny after the U.S. Department of Commerce raised duties on Chinese battery‑grade graphite to 160%+ in final determinations. The move tightens U.S. access to lower‑cost graphite, potentially reshaping sourcing, margins and capex plans across EV and battery materials names.
Materials and mining stocks are likely to react as companies reassess supply‑chain exposure and potential reshoring or domestic processing investments.
Mining, Exploration and Resource Updates
Agnico Eagle (AEM) released an update on 2025 exploration results and 2026 plans, showing a 2% rise in mineral reserves to 55.4 million ounces and double‑digit gains in indicated and inferred resources. The numbers matter for long‑term production profiles and capital allocation across its portfolio.
Galiano Gold (GAU) posted a mineral reserve/resource update that includes maiden underground resources at Nkran and Abore, and also released Q4 and FY25 results. Together, the technical and financials give investors a clearer line of sight on project economics and development timing.
Healthcare and Biotech Approvals
Emergent BioSolutions (EBS) received FDA approval of an sNDA for NARCAN® nasal spray multipacks. That regulatory green light can increase product availability in public‑health channels and support recurring revenue in the emergency‑medicines segment.
Other biotech and pharma results—like updates from Ultragenyx (RARE) and program reports from CRISPR Therapeutics (CRSP)—remain items investors will parse for pipeline timelines and cash runway implications.
Listings, Index Moves and Market Access
iRen (IREN) was added to the MSCI USA Index, a change that typically brings inflows from index‑tracking funds and can support near‑term valuation pressure reduction for small‑cap names experiencing increased passive demand.
Separately, Braiin Ltd. (BRAI) continues toward a Nasdaq listing that expands investor access to bitcoin‑mining infrastructure exposure.
M&A, SPACs and Corporate Filings
Enhanced and A Paradise Acquisition Corp. (APAD) filed a registration statement on Form S‑4, advancing a proposed business combination and potential de‑SPAC timeline that investors will watch for deal terms and dilution details.
Aura FAT Projects Acquisition Corp (AFAR) signed a binding LOI with Dalmore for a proposed business combination, signaling renewed SPAC activity in the acquisition pipeline.
Big Earnings, Guidance and Market Dates
Chip‑equipment and networking bellwethers like Applied Materials (AMAT) and Arista Networks (ANET) continue to top the calendar; their results will inform the semiconductor capex and hyperscaler demand narratives.
Tucows (TCX) blew past guidance with a strong fiscal 2025 beat and launched a $40 million buyback, reinforcing shareholder‑return dynamics for cash‑generative internet services.
Calendar Watch: Earnings and Corporate Dates to Note
- Treace (TMCI) updated the date of its Q4 and FY25 results release to Feb. 27, 2026.
- Neptune Insurance Holdings (NP) will announce Q4 2025 financial results; insurers' reserve commentary will be relevant for underwriting outlooks.
- Also watch upcoming calls or releases from DigitalBridge (DBRG), Norwegian Cruise Line (NCLH), Arista, Applied Materials and Vertex (VRTX).
Selected Small‑Cap Operational Notes
- OneMedNet (ONMD) reported record 2025 bookings of $2.79 million, signaling accelerating subscription adoption.
- Roadzen (RDZN) posted a strong quarter with $14.4 million in revenue and improving EBITDA trends.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement